Clinical Trial Update: Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention [NA]

View source ↗

Summary

An ongoing clinical trial at Samsung Medical Center evaluating a triple therapy of dexamethasone, palonosetron, and fosaprepitant for prevention of postoperativ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)
• Palonosetron (palonosetron)

Snippet

Sponsor: Samsung Medical Center | Conditions: Postoperative Nausea and Vomiting, Gynecologic Surgical Procedures | NA | Status: ENROLLING_BY_INVITATION